Wells Fargo’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Wells Fargo’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39	Hold	1	–	–	﹤0.01%	6645
2025 Q4	$38	Hold	1	–	–	﹤0.01%	6585
2025 Q3	$22	Hold	1	–	–	﹤0.01%	6682
2025 Q2	$107	Hold	1	–	–	﹤0.01%	6473
2025 Q1	$103	Hold	1	–	–	﹤0.01%	6373
2024 Q4	$218	Hold	1	–	–	﹤0.01%	6355
2024 Q3	$122	Hold	1	–	–	﹤0.01%	6262
2024 Q2	$128	Sell	1 -2	-67%	-$249	﹤0.01%	6230
2024 Q1	$535	Hold	3	–	–	﹤0.01%	6265
2023 Q4	$400	Buy	3 +1	+50%	+$156	﹤0.01%	6434
2023 Q3	$424	Hold	2	–	–	﹤0.01%	6398
2023 Q2	$365	Hold	2	–	–	﹤0.01%	6550
2023 Q1	$268	Hold	2	–	–	﹤0.01%	6697
2022 Q4	$235	Sell	2 -1	-33%	-$200	﹤0.01%	6575
2022 Q3	$0	Buy	3 +1	+50%	+$320	﹤0.01%	7460
2022 Q2	$0	Hold	2	–	–	﹤0.01%	7585
2022 Q1	$1K	Hold	2	–	–	﹤0.01%	6877
2021 Q4	$1K	Buy	+2	New	+$2.15K	﹤0.01%	7089
2021 Q2	–	Sell	-9	Closed	-$53K	–	7509
2021 Q1	$53K	Sell	9 -26	-74%	-$189K	﹤0.01%	5793
2020 Q4	$200K	Buy	35 +5	+17%	+$31.4K	﹤0.01%	5089
2020 Q3	$181K	Sell	30 -2	-6%	-$11.7K	﹤0.01%	5008
2020 Q2	$200K	Buy	32 +17	+113%	+$115K	﹤0.01%	4914
2020 Q1	$143K	Buy	15 +6	+67%	+$94.1K	﹤0.01%	4880
2019 Q4	$152K	Hold	9	–	–	﹤0.01%	5111
2019 Q3	$152K	Buy	9 +1	+13%	+$16.1K	﹤0.01%	5119
2019 Q2	$180K	Buy	8 +1	+14%	+$24.7K	﹤0.01%	5031
2019 Q1	$184K	Buy	7 +3	+75%	+$72K	﹤0.01%	4867
2018 Q4	$64K	Buy	+4	New	+$89.5K	﹤0.01%	5449
2018 Q3	–	Hold	0	–	–	–	5900
2018 Q2	–	Hold	0	–	–	–	6066
2018 Q1	–	Hold	0	–	–	–	5642

Other funds holding YARW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $134M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Wells Fargo's YARW Position: Q1 2026 in Review

Wells Fargo held its Yarrow Bioscience, Inc. Common Stock (YARW) position steady in Q1 2026 at 1 share worth $39. The position accounts for ﹤0.01% of the portfolio, ranked #6645.

Wells Fargo first reported a position in YARW in Q4 2018 and has held it in 28 quarters since. The position peaked at $200K in Q4 2020. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

Wells Fargo held 1 share of Yarrow Bioscience, Inc. Common Stock worth $39 as of Q1 2026.
Wells Fargo left its Yarrow Bioscience, Inc. Common Stock share count unchanged in Q1 2026.
Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6645 holding.
Wells Fargo first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2018 and has held it in 28 quarters since.
Wells Fargo's Yarrow Bioscience, Inc. Common Stock position peaked at $200K in Q4 2020.
42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.